By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Medical University of Vienna: New therapy option doubles the life span of B-cell lymphoma patients

infusion © pixabay

That is the main finding of the multi-center JULIET study, in which researchers from the Comprehensive Cancer Centre (CCC) of the Medical University of Vienna and Vienna General Hospital participated. In CAR-T cell therapy, previously modified T-cells recognize a specific protein on the surface of the tumor. This in turn triggers destruction of the tumor cells. This introduces a new option for treating such patients. This is because the two-year survival rate following standard treatment is only 20 percent, whereas, with CAR-T cell therapy, overall survival has doubled to 40%. The results of this study were published in the New England Journal of Medicine.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • ABA's Virtual Open Day Reloaded

    01.10.2020/ 14pm - 15pm (CET), Virtual Event

  • Austria - Oportunități pentru companii românești

    05.10.2020/ | 16:30 - 18:30, București, Romania

Austria Map

Find the perfect location for your company

Thanks to a fantastic mindset, our employees at the Villach site have built up a unique expertise which helps us to further strengthen our position on the global market. We fuse high-performance manufacturing with research and development in the field of power electronics. In addition to a very good cooperation with partners and networks, a well-developed landscape of 'talent factories' ranging from higher technical colleges to universities, we as a company also value the outstanding model of research promotion which exists in Austria.

Infineon

Logo Infineon
More testimonials

news from the business location Austria

Investment for augmented reality startup Amlogy

Augmented reality (AR) has always been a passion for Arkadi Jeghiazaryan.

Innovations from Vienna are a Growth Driver

Multinational companies invest € 2 billion in research in Austria every year. Many of the subsidiaries based in Austria carry out research and development activities in the Alpine Republic. Our company also does so. Ottobock has been operating in Austria for more than 50 years.

More news All blog posts